To date, over $100 million has been invested in developing Cellana’s algae strains, patented and proprietary production technologies, and its Kona Demonstration Facility.

Cellana has received funding from grants, government contracts, and strategic partners, as well as equity investments from individual accredited investors.

Cellana is grateful to the US Department of Energy (DOE), the US Department of Agriculture (USDA), and the US Department of Defense (DOD), for their historic and continued support and trust in Cellana’s approach to addressing the global need for algae-based products.

The Company is in the process of Series A financing for its ongoing growth and further commercialization.

For more information about Cellana, please contact us.